Just as CUPIDO is developing inhalable nanoparticles to deliver a drug to the heart, several other European projects — using very different compounds to treat very different ailments — have all turned to nanoparticles for drug delivery. These include the New Deal project, which is developing a nano-formulated RNA based therapy to treat inflammatory bowel disease, the B-Smart project, centered on delivering drugs to the brain to treat neurodegenerative disorders, and the Smart-4-Fabry project, which is applying nanotech to treat the rare Fabry disease.
While the field of application differs, similar are the challenges that the projects had to face, especially when dealing with scale-up. For this reason, the 4 projects came together at the European Technology Platform on Nanomedicine conference (ETPN2020, 14-15 Oct) to discuss the lessons learned in a virtual workshop.
